Cargando…

Fetal Growth Restriction – Diagnostic Work-up, Management and Delivery

Fetal or intrauterine growth restriction (FGR/IUGR) affects approximately 5 – 8% of all pregnancies and refers to a fetus not exploiting its genetically determined growth potential. Not only a major cause of perinatal morbidity and mortality, it also predisposes these fetuses to the development of c...

Descripción completa

Detalles Bibliográficos
Autor principal: Schlembach, Dietmar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7518933/
https://www.ncbi.nlm.nih.gov/pubmed/33012833
http://dx.doi.org/10.1055/a-1232-1418
_version_ 1783587475332005888
author Schlembach, Dietmar
author_facet Schlembach, Dietmar
author_sort Schlembach, Dietmar
collection PubMed
description Fetal or intrauterine growth restriction (FGR/IUGR) affects approximately 5 – 8% of all pregnancies and refers to a fetus not exploiting its genetically determined growth potential. Not only a major cause of perinatal morbidity and mortality, it also predisposes these fetuses to the development of chronic disorders in later life. Apart from the timely diagnosis and identification of the causes of FGR, the obstetric challenge primarily entails continued antenatal management with optimum timing of delivery. In order to minimise premature birth morbidity, intensive fetal monitoring aims to prolong the pregnancy and at the same time intervene, i.e. deliver, before the fetus is threatened or harmed. It is important to note that early-onset FGR (< 32 + 0 weeks of gestation [wks]) should be assessed differently than late-onset FGR (≥ 32 + 0 wks). In early-onset FGR progressive deterioration is reflected in abnormal venous Doppler parameters, while in late-onset FGR this manifests primarily in abnormal cerebral Doppler ultrasound. According to our current understanding, the “optimum” approach for monitoring and timing of delivery in early-onset FGR combines computerized CTG with the ductus venosus Doppler, while in late-onset FGR assessment of the cerebral Doppler parameters becomes more important.
format Online
Article
Text
id pubmed-7518933
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Georg Thieme Verlag KG
record_format MEDLINE/PubMed
spelling pubmed-75189332020-10-01 Fetal Growth Restriction – Diagnostic Work-up, Management and Delivery Schlembach, Dietmar Geburtshilfe Frauenheilkd Fetal or intrauterine growth restriction (FGR/IUGR) affects approximately 5 – 8% of all pregnancies and refers to a fetus not exploiting its genetically determined growth potential. Not only a major cause of perinatal morbidity and mortality, it also predisposes these fetuses to the development of chronic disorders in later life. Apart from the timely diagnosis and identification of the causes of FGR, the obstetric challenge primarily entails continued antenatal management with optimum timing of delivery. In order to minimise premature birth morbidity, intensive fetal monitoring aims to prolong the pregnancy and at the same time intervene, i.e. deliver, before the fetus is threatened or harmed. It is important to note that early-onset FGR (< 32 + 0 weeks of gestation [wks]) should be assessed differently than late-onset FGR (≥ 32 + 0 wks). In early-onset FGR progressive deterioration is reflected in abnormal venous Doppler parameters, while in late-onset FGR this manifests primarily in abnormal cerebral Doppler ultrasound. According to our current understanding, the “optimum” approach for monitoring and timing of delivery in early-onset FGR combines computerized CTG with the ductus venosus Doppler, while in late-onset FGR assessment of the cerebral Doppler parameters becomes more important. Georg Thieme Verlag KG 2020-10 2020-09-25 /pmc/articles/PMC7518933/ /pubmed/33012833 http://dx.doi.org/10.1055/a-1232-1418 Text en The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/) https://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited.
spellingShingle Schlembach, Dietmar
Fetal Growth Restriction – Diagnostic Work-up, Management and Delivery
title Fetal Growth Restriction – Diagnostic Work-up, Management and Delivery
title_full Fetal Growth Restriction – Diagnostic Work-up, Management and Delivery
title_fullStr Fetal Growth Restriction – Diagnostic Work-up, Management and Delivery
title_full_unstemmed Fetal Growth Restriction – Diagnostic Work-up, Management and Delivery
title_short Fetal Growth Restriction – Diagnostic Work-up, Management and Delivery
title_sort fetal growth restriction – diagnostic work-up, management and delivery
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7518933/
https://www.ncbi.nlm.nih.gov/pubmed/33012833
http://dx.doi.org/10.1055/a-1232-1418
work_keys_str_mv AT schlembachdietmar fetalgrowthrestrictiondiagnosticworkupmanagementanddelivery